| Year |
Citation |
Score |
| 2020 |
Shah P, Suriany S, Kato R, Bush AM, Chalacheva P, Veluswamy S, Denton CC, Russell K, Khaleel M, Forman HJ, Khoo MCK, Sposto R, Coates TD, Wood JC, Detterich J. Tricuspid regurgitant jet velocity and myocardial tissue doppler parameters predict mortality in a cohort of patients with sickle cell disease spanning from pediatric to adult age groups - revisiting this controversial concept after sixteen years of additional evidence. American Journal of Hematology. PMID 32944977 DOI: 10.1002/Ajh.26003 |
0.311 |
|
| 2020 |
Goldberg J, Bender J, Jeha S, Sulis ML, Gardner R, Pollard J, Aquino V, Laetsch T, Winick N, Fu C, Marcus L, Sun W, Verma A, Burke M, Ho P, ... ... Sposto R, et al. A phase I study of panobinostat in children with relapsed and refractory hematologic malignancies. Pediatric Hematology and Oncology. 1-10. PMID 32338562 DOI: 10.1080/08880018.2020.1752869 |
0.347 |
|
| 2020 |
Dhall G, O'Neil SH, Ji L, Haley K, Whitaker AM, Nelson MD, Gilles F, Gardner SL, Allen JC, Cornelius AS, Pradhan K, Garvin JH, Olshefski RS, Hukin J, Comito M, ... ... Sposto R, et al. Excellent Outcome of Young Children with Nodular Desmoplastic Medulloblastoma Treated on "Head Start" III: A Multi-Institutional, Prospective Clinical Trial. Neuro-Oncology. PMID 32304218 DOI: 10.1093/Neuonc/Noaa102 |
0.358 |
|
| 2020 |
Locatelli F, Whitlock JA, Peters C, Chen-Santel C, Chia V, Dennis RM, Heym KM, Katz AJ, Kelsh MA, Sposto R, Tu H, Tuglus CA, Verma A, Vinti L, Wilkes JJ, et al. Blinatumomab versus historical standard therapy in pediatric patients with relapsed/refractory Ph-negative B-cell precursor acute lymphoblastic leukemia. Leukemia. PMID 32094465 DOI: 10.1038/S41375-020-0770-8 |
0.321 |
|
| 2020 |
Oberley MJ, Raikar SS, Wertheim GB, Malvar J, Sposto R, Rabin KR, Punia JN, Seif AE, Cahen VC, Schore RJ, Luca DC, Guinipero T, Woods WG, O'Gorman MRG, Orgel E. Significance of minimal residual disease in pediatric mixed phenotype acute leukemia: a multicenter cohort study. Leukemia. PMID 32060402 DOI: 10.1038/S41375-020-0741-0 |
0.388 |
|
| 2019 |
Pommert L, Bhojwani D, Sposto R, Florendo E, Schafer E, Gossai N, Huynh VT, Rao S, Burke MJ. Phase 1 Study of Decitabine and Vorinostat Followed By Fludarabine, Cytarabine and G-CSF (FLAG) in Children, Adolescents and Young Adults with Relapsed/Refractory AML: Report from the Therapeutic Advances in Childhood Leukemia and Lymphoma (TACL) Consortium Blood. 134: 1325-1325. DOI: 10.1182/Blood-2019-127298 |
0.329 |
|
| 2018 |
Osorio DS, Patel N, Ji L, Sposto R, Stanek J, Gardner SL, Allen JC, Cornelius A, McCowage GB, Termuhlen A, Dunkel IJ, Comito M, Garvin J, Finlay JL. Pre-irradiation intensive induction and marrow-ablative consolidation chemotherapy in young children with newly diagnosed high-grade brainstem gliomas: report of the "head-start" I and II clinical trials. Journal of Neuro-Oncology. PMID 30392092 DOI: 10.1007/S11060-018-03003-Z |
0.388 |
|
| 2018 |
Bhojwani D, Sposto R, Shah NN, Rodriguez V, Yuan C, Stetler-Stevenson M, O'Brien MM, McNeer JL, Raetz EA, Loh ML, Rheingold SR. Inotuzumab ozogamicin in pediatric patients with relapsed/refractory acute lymphoblastic leukemia. Leukemia. PMID 30267011 DOI: 10.1038/S41375-018-0265-Z |
0.403 |
|
| 2018 |
Sun W, Malvar J, Sposto R, Verma A, Wilkes JJ, Dennis R, Heym K, Laetsch TW, Widener M, Rheingold SR, Oesterheld J, Hijiya N, Sulis ML, Huynh V, Place AE, et al. Outcome of children with multiply relapsed B-cell acute lymphoblastic leukemia: a therapeutic advances in childhood leukemia & lymphoma study. Leukemia. PMID 29728694 DOI: 10.1038/S41375-018-0094-0 |
0.345 |
|
| 2018 |
Ng LW, Wong KK, Ally Wu CL, Sposto R, Olch AJ. Dose Sculpting Intensity Modulated Radiation Therapy for Vertebral Body Sparing in Children With Neuroblastoma. International Journal of Radiation Oncology, Biology, Physics. PMID 29680256 DOI: 10.1016/J.Ijrobp.2018.02.015 |
0.301 |
|
| 2018 |
Webb MW, Sun J, Sheard MA, Liu WY, Wu HW, Jackson JR, Malvar J, Sposto R, Daniel D, Seeger RC. Colony Stimulating Factor 1 Receptor Blockade Improves the Efficacy of Chemotherapy against Human Neuroblastoma in the Absence of T Lymphocytes. International Journal of Cancer. PMID 29665011 DOI: 10.1002/Ijc.31532 |
0.325 |
|
| 2018 |
Maruffi M, Sposto R, Oberley MJ, Kysh L, Orgel E. Therapy for children and adults with mixed phenotype acute leukemia: a systematic review and meta-analysis. Leukemia. PMID 29550836 DOI: 10.1038/S41375-018-0058-4 |
0.363 |
|
| 2018 |
Robison NJ, Yeo KK, Berliner AP, Malvar J, Sheard MA, Margol AS, Seeger RC, Rushing T, Finlay JL, Sposto R, Dhall G. Phase I trial of dasatinib, lenalidomide, and temozolomide in children with relapsed or refractory central nervous system tumors. Journal of Neuro-Oncology. PMID 29427149 DOI: 10.1007/S11060-018-2791-Y |
0.378 |
|
| 2018 |
Villablanca JG, Ji L, Shapira-Lewinson A, Marachelian A, Shimada H, Hawkins RA, Pampaloni M, Lai H, Goodarzian F, Sposto R, Park JR, Matthay KK. Predictors of response, progression-free survival, and overall survival using NANT Response Criteria (v1.0) in relapsed and refractory high-risk neuroblastoma. Pediatric Blood & Cancer. PMID 29350464 DOI: 10.1002/Pbc.26940 |
0.334 |
|
| 2018 |
Sun W, Triche T, Malvar J, Gaynon P, Sposto R, Yang X, Bittencourt H, Place AE, Messinger Y, Fraser C, Dalla-Pozza L, Salhia B, Jones P, Wayne AS, Gore L, et al. A phase 1 study of azacitidine combined with chemotherapy in childhood leukemia: a report from TACL consortium. Blood. PMID 29339403 DOI: 10.1182/Blood-2017-09-803809 |
0.395 |
|
| 2018 |
Marachelian A, Villablanca J, Duvalyan A, Czarnecki S, Groshen SG, Tsao-Wei D, Sposto R, Malvar J, Sun J, Goldsmith KC, Mosse YP, Granger M, Seibel N, Moscow J, Matthay KK, et al. A phase I NANT study of lenalidomide with ch14.18 and isotretinoin (RA) in patients with refractory/recurrent neuroblastoma (RR-NB). Journal of Clinical Oncology. 36: 10522-10522. DOI: 10.1200/Jco.2018.36.15_Suppl.10522 |
0.303 |
|
| 2018 |
Branchford BR, Jaffray J, Croteau SE, Silvey M, Bakeer N, Cooper JD, Fargo JH, Ji L, Sposto R, Malvar J, Krava E, Stillings A, Goldenberg NA, Young G, Mahajerin A. Risk Factors for Hospital-Acquired Venous Thromboembolism in Children: Findings from the Children's Hospital-Acquired Thrombosis (CHAT) Registry Blood. 132: 142-142. DOI: 10.1182/Blood-2018-99-119968 |
0.318 |
|
| 2018 |
Shah P, Bush A, Suriany S, Liu H, Forman HJ, Chalacheva P, Thuptimdang W, Sunwoo J, Veluswamy S, Denton CC, Khaleel M, Kato RM, Perumbeti A, Sposto R, Khoo M, et al. Hemolysis and Tricuspid Regurgitation Jet Velocity Predict Mortality in Patients with Sickle Cell Disease Blood. 132: 1086-1086. DOI: 10.1182/Blood-2018-99-119587 |
0.344 |
|
| 2018 |
O'Connell CL, Kropf PL, Punwani N, Rogers D, Sposto R, Grønbæk K. Phase I Results of a Multicenter Clinical Trial Combining Guadecitabine, a DNA Methyltransferase Inhibitor, with Atezolizumab, an Immune Checkpoint Inhibitor, in Patients with Relapsed or Refractory Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia Blood. 132: 1811-1811. DOI: 10.1182/Blood-2018-99-117658 |
0.361 |
|
| 2018 |
Oberley MJ, Wertheim G, Raikar SS, Malvar J, Sposto R, Punia JN, Rabin KR, Seif AE, Schore RJ, Luca DC, Guinipero T, Woods WG, O'Gorman MR, Orgel E. Clinical Outcomes in Pediatric Mixed Phenotype Acute Leukemia (MPAL) Differ Depending on Disease Classification Criteria; A Multi-Center Cohort Study Blood. 132: 4080-4080. DOI: 10.1182/Blood-2018-99-117377 |
0.341 |
|
| 2018 |
Oberley MJ, Raikar SS, Malvar J, Wertheim G, Seif AE, Guinipero T, Sposto R, Rabin KR, Punia JN, Schore RJ, Luca DC, Woods WG, O'Gorman MR, Orgel E. Minimal Residual Disease Risk-Stratification in Pediatric Mixed Phenotype Acute Leukemia: Results of a Multi-Center Cohort Study Blood. 132: 558-558. DOI: 10.1182/Blood-2018-99-113606 |
0.422 |
|
| 2017 |
Wayne AS, Shin-Kashiyama E, Sposto R, Gaynon P. Therapeutic Advances in Childhood Leukemia and Lymphoma (TACL): Overview and introduction to the proceedings of the 2016 TACL investigator meeting. Pediatric Hematology and Oncology. 1-6. PMID 29120691 DOI: 10.1080/08880018.2017.1377329 |
0.345 |
|
| 2017 |
Pan E, Tung L, Ragab O, Morocco E, Wecsler J, Sposto R, Raghavendra A, Chung E, Lang JE. Inflammatory Breast Cancer Outcomes in a Contemporary Series. Anticancer Research. 37: 5057-5063. PMID 28870934 DOI: 10.21873/Anticanres.11922 |
0.309 |
|
| 2017 |
Guerra JA, Dhall G, Marachelian A, Castillo E, Malvar J, Wong K, Sposto R, Finlay JL. Marrow-ablative chemotherapy followed by tandem autologous hematopoietic cell transplantation in pediatric patients with malignant brain tumors. Bone Marrow Transplantation. PMID 28783147 DOI: 10.1038/Bmt.2017.166 |
0.373 |
|
| 2017 |
Borriello L, Nakata R, Sheard MA, Fernandez GE, Sposto R, Malvar J, Blavier L, Shimada H, Asgharzadeh S, Seeger RC, DeClerck YA. Cancer-Associated Fibroblasts Share Characteristics and Pro-tumorigenic Activity with Mesenchymal Stromal Cells. Cancer Research. PMID 28687621 DOI: 10.1158/0008-5472.Can-16-2586 |
0.324 |
|
| 2017 |
Marachelian A, Villablanca JG, Liu CW, Liu B, Goodarzian F, Lai HA, Shimada H, Tran HC, Parra JA, Gallego R, Bedrossian N, Young S, Czarnecki S, Kennedy R, Weiss B, ... ... Sposto R, et al. Expression of Five Neuroblastoma Genes in Bone Marrow or Blood of Patients with Relapsed/Refractory Neuroblastoma Provides a New Biomarker for Disease and Prognosis. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 28559462 DOI: 10.1158/1078-0432.Ccr-16-2647 |
0.328 |
|
| 2017 |
Soni S, Abdel-Azim H, McManus M, Nemecek E, Sposto R, Woolfrey A, Frangoul H. Phase I Study of Clofarabine and 2-Gy Total Body Irradiation as a Non-Myeloablative Preparative Regimen for Hematopoietic Stem Cell Transplantation (HSCT) in Pediatric Patients with Hematologic Malignancies: a Therapeutic Advances in Childhood Leukemia (TACL) Consortium Study. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 28396162 DOI: 10.1016/J.Bbmt.2017.03.037 |
0.383 |
|
| 2017 |
Maruffi MA, Sposto R, Oberley MJ, Kysh L, Orgel E. Therapy for Children and Adults with EGIL- or WHO2008-Defined Mixed Phenotype Acute Leukemia: A Systematic Review and Meta-Analysis Blood. 130: 2609-2609. DOI: 10.1182/Blood.V130.Suppl_1.2609.2609 |
0.351 |
|
| 2017 |
Robison N, Pauly J, Malvar J, Filbin M, de Mola RL, Dorris K, Bendel A, Bowers D, Bornhorst M, Gauvain K, Leary S, MacDonald T, Gardner S, Reddy A, Diaz P, ... ... Sposto R, et al. PDCT-24. A PHASE I DOSE ESCALATION TRIAL OF THE MEK1/2 INHIBITOR MEK162 (BINIMETINIB) IN CHILDREN WITH LOW-GRADE GLIOMAS AND OTHER RAS-RAF PATHWAY-ACTIVATED TUMORS: INITIAL REPORT Neuro-Oncology. 19: vi189-vi189. DOI: 10.1093/Neuonc/Nox168.765 |
0.319 |
|
| 2017 |
Dhall G, Ji L, Haley K, Gilles F, Gardner S, Sposto R, Finlay JL. P11.02 Long-term Outcome of Infants and Young Children with Newly Diagnosed Non-Nodular/Desmoplastic Medulloblastoma Treated on “Head Start” III Protocol Neuro-Oncology. 19: iii91-iii92. DOI: 10.1093/Neuonc/Nox036.347 |
0.381 |
|
| 2016 |
Piatek CI, Ji L, Kaur C, Russell CA, Tripathy D, Church T, Sposto R, Sener SF, Garcia AA. Value of routine staging imaging studies for patients with stage III breast cancer. Journal of Surgical Oncology. PMID 27642105 DOI: 10.1002/Jso.24436 |
0.302 |
|
| 2016 |
Sun W, Orgel E, Malvar J, Sposto R, Wilkes JJ, Gardner R, Tolbert VP, Smith A, Hur M, Hoffman J, Rheingold SR, Burke MJ, Wayne AS. Treatment-related adverse events associated with a modified UK ALLR3 induction chemotherapy backbone for childhood relapsed/refractory acute lymphoblastic leukemia. Pediatric Blood & Cancer. PMID 27437864 DOI: 10.1002/Pbc.26129 |
0.342 |
|
| 2016 |
Espinoza JC, Haley K, Patel N, Dhall G, Gardner S, Allen J, Torkildson J, Cornelius A, Rassekh R, Bedros A, Etzl M, Garvin J, Pradhan K, Corbett R, Sullivan M, ... ... Sposto R, et al. Outcome of young children with high-grade glioma treated with irradiation-avoiding intensive chemotherapy regimens: Final report of the Head Start II and III trials. Pediatric Blood & Cancer. PMID 27332770 DOI: 10.1002/Pbc.26118 |
0.389 |
|
| 2016 |
Ater JL, Xia C, Mazewski CM, Booth TN, Freyer DR, Packer RJ, Sposto R, Vezina G, Pollack IF. Nonrandomized comparison of neurofibromatosis type 1 and non-neurofibromatosis type 1 children who received carboplatin and vincristine for progressive low-grade glioma: A report from the Children's Oncology Group. Cancer. PMID 27061921 DOI: 10.1002/Cncr.29987 |
0.383 |
|
| 2016 |
Cooper TM, Cassar J, Eckroth E, Malvar J, Sposto R, Gaynon P, Chang BH, Gore L, August K, Pollard JA, Dubois SG, Silverman LB, Oesterheld J, Gammon G, Magoon D, et al. A Phase I Study of Quizartinib Combined With Chemotherapy in Relapsed Childhood Leukemia: A Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) Study. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 26920889 DOI: 10.1158/1078-0432.Ccr-15-1998 |
0.382 |
|
| 2016 |
Rawlins Y, Malvar J, Sposto R, Orgel E, Bhojwani D. Investigating Ethnic Differences in Toxicities of Childhood ALL Therapy Blood. 128: 5989-5989. DOI: 10.1182/Blood.V128.22.5989.5989 |
0.421 |
|
| 2016 |
Burke MJ, Brown P, Sposto R, Gore L, Wayne AS. Pilot Study of Decitabine and Vorinostat with Chemotherapy for Relapsed ALL: A Report from the Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) Consortium Blood. 128: 2781-2781. DOI: 10.1182/Blood.V128.22.2781.2781 |
0.391 |
|
| 2016 |
Evans A, Garretson C, Pedroja E, Malvar J, Margol A, Sposto R, Nelson MB. Nu-12The Use Of Aromatherapy To Reduce Chemotherapy-Induced Nausea In Children With Cancer; A Randomized, Double Blind, Placebo Controlled Trial. Neuro-Oncology. 18. DOI: 10.1093/Neuonc/Now079.12 |
0.328 |
|
| 2016 |
Farzingohar S, Xia C, Sposto R, Freyer D, Dhall G. Mb-101Toxicity And Outcome In Adolescent And Young Adults (Aya) Treated For Medulloblastoma (Mb) And Primitive Neuroectodermal Tumors (Pnet) On Cog-A9961 And Ccg-99701: A Report From The Children'S Oncology Group (Cog). Neuro-Oncology. 18. DOI: 10.1093/Neuonc/Now076.96 |
0.329 |
|
| 2016 |
Margol A, Xia C, Sposto R, Freyer D, Dhall G. Lg-65Clinicopathological Features And Outcome In Adolescents/Young Adults (Aya) With Low Grade Glioma (Lgg) Compared With Children: A Report From The Children'S Oncology Group Neuro-Oncology. 18. DOI: 10.1093/Neuonc/Now075.65 |
0.377 |
|
| 2015 |
Meeske KA, Ji L, Freyer DR, Gaynon P, Ruccione K, Butturini A, Avramis VI, Siegel S, Matloub Y, Seibel NL, Sposto R. Comparative Toxicity by Sex Among Children Treated for Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group. Pediatric Blood & Cancer. 62: 2140-9. PMID 26173904 DOI: 10.1002/Pbc.25628 |
0.371 |
|
| 2015 |
Sun W, Gaynon PS, Sposto R, Wayne AS. Improving access to novel agents for childhood leukemia. Cancer. 121: 1927-36. PMID 25678105 DOI: 10.1002/Cncr.29267 |
0.341 |
|
| 2015 |
Margol AS, Robison NJ, Gnanachandran J, Hung LT, Kennedy RJ, Vali M, Dhall G, Finlay JL, Erdreich-Epstein A, Krieger MD, Drissi R, Fouladi M, Gilles FH, Judkins AR, Sposto R, et al. Tumor-associated macrophages in SHH subgroup of medulloblastomas. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 21: 1457-65. PMID 25344580 DOI: 10.1158/1078-0432.Ccr-14-1144 |
0.314 |
|
| 2015 |
Sun W, Malvar J, Sposto R, Verma A, Wilkes JJ, Dennis RM, Heym KM, Eckroth E, Vandergiesse J, Gaynon PS, Wayne AS, Whitlock JA. Re-Induction Outcome for Pediatric Patients with Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia: A Retrospective Cohort Study of the Therapeutic Advances in Childhood Leukemia Consortium Blood. 126: 3760-3760. DOI: 10.1182/Blood.V126.23.3760.3760 |
0.392 |
|
| 2015 |
Isenalumhe LL, Margol AS, Louie S, Neely M, Sposto R, Malvar J, Freyer DR. Comparison of Vincristine Pharmacokinetics (PK) in Adolescent/Young Adult (AYA) Versus Younger Patients Defined By Tanner Stage during Treatment for Acute Lymphoblastic Leukemia (ALL) Blood. 126: 3725-3725. DOI: 10.1182/Blood.V126.23.3725.3725 |
0.374 |
|
| 2015 |
Ko RH, Sposto R, Goodarzian F, Carmona R, Vasquez S, Young G. Thromboelastography to Detect Hypercoagulability in Patients with Newly Diagnosed Acute Lymphoblastic Leukemia Blood. 126: 1118-1118. DOI: 10.1182/Blood.V126.23.1118.1118 |
0.374 |
|
| 2015 |
Shariff-Marco S, Kurian AW, Yang J, Koo J, John EM, Keegan THM, Cheng I, Monroe KR, Vigen C, Kwan ML, Lu Y, Henderson BE, Bernstein L, Sposto R, Wu AH, et al. Abstract A67: Do hospital characteristics explain racial/ethnic disparities in mortality after breast cancer diagnosis: The California Breast Cancer Survivorship Consortium Cancer Epidemiology, Biomarkers & Prevention. 24. DOI: 10.1158/1538-7755.Disp14-A67 |
0.302 |
|
| 2014 |
Orgel E, Tucci J, Alhushki W, Malvar J, Sposto R, Fu CH, Freyer DR, Abdel-Azim H, Mittelman SD. Obesity is associated with residual leukemia following induction therapy for childhood B-precursor acute lymphoblastic leukemia. Blood. 124: 3932-8. PMID 25349177 DOI: 10.1182/Blood-2014-08-595389 |
0.314 |
|
| 2014 |
Solari V, Borriello L, Turcatel G, Shimada H, Sposto R, Fernandez GE, Asgharzadeh S, Yates EA, Turnbull JE, DeClerck YA. MYCN-dependent expression of sulfatase-2 regulates neuroblastoma cell survival. Cancer Research. 74: 5999-6009. PMID 25164011 DOI: 10.1158/0008-5472.Can-13-2513 |
0.331 |
|
| 2014 |
Ruccione KS, Wood JC, Sposto R, Malvar J, Chen C, Freyer DR. Characterization of transfusion-derived iron deposition in childhood cancer survivors. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 23: 1913-9. PMID 24962841 DOI: 10.1158/1055-9965.Epi-14-0292 |
0.311 |
|
| 2014 |
Kang MH, Villablanca JG, Glade Bender JL, Matthay KK, Groshen S, Sposto R, Czarnecki S, Ames MM, Reynolds CP, Marachelian A, Maurer BJ. Probable fatal drug interaction between intravenous fenretinide, ceftriaxone, and acetaminophen: a case report from a New Approaches to Neuroblastoma (NANT) Phase I study. Bmc Research Notes. 7: 256. PMID 24755475 DOI: 10.1186/1756-0500-7-256 |
0.305 |
|
| 2014 |
Orgel E, Sposto R, Malvar J, Seibel NL, Ladas E, Gaynon PS, Freyer DR. Impact on survival and toxicity by duration of weight extremes during treatment for pediatric acute lymphoblastic leukemia: A report from the Children's Oncology Group. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 32: 1331-7. PMID 24687836 DOI: 10.1200/Jco.2013.52.6962 |
0.342 |
|
| 2014 |
Antony R, Wong KE, Patel M, Olch AJ, McComb G, Krieger M, Gilles F, Sposto R, Erdreich-Epstein A, Dhall G, Gardner S, Finlay JL. A retrospective analysis of recurrent intracranial ependymoma. Pediatric Blood & Cancer. 61: 1195-201. PMID 24615997 DOI: 10.1002/Pbc.24996 |
0.313 |
|
| 2014 |
Venkatramani R, Kamath S, Wong K, Olch AJ, Malvar J, Sposto R, Goodarzian F, Freyer DR, Keens TG, Mascarenhas L. Pulmonary outcomes in patients with Hodgkin lymphoma treated with involved field radiation. Pediatric Blood & Cancer. 61: 1277-81. PMID 24482138 DOI: 10.1002/Pbc.24969 |
0.306 |
|
| 2014 |
Erdreich-Epstein A, Robison N, Ren X, Zhou H, Xu J, Davidson TB, Schur M, Gilles FH, Ji L, Malvar J, Shackleford GM, Margol AS, Krieger MD, Judkins AR, Jones DT, ... ... Sposto R, et al. PID1 (NYGGF4), a new growth-inhibitory gene in embryonal brain tumors and gliomas. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 827-36. PMID 24300787 DOI: 10.1158/1078-0432.Ccr-13-2053 |
0.34 |
|
| 2014 |
Raetz EA, Morrison D, Romanos-Sirakis E, Gaynon P, Sposto R, Bhojwani D, Bostrom BC, Brown P, Eckroth E, Cassar J, Malvar J, Buchbinder A, Carroll WL. A phase I study of EZN-3042, a novel survivin messenger ribonucleic acid (mRNA) antagonist, administered in combination with chemotherapy in children with relapsed acute lymphoblastic leukemia (ALL): a report from the therapeutic advances in childhood leukemia and lymphoma (TACL) consortium. Journal of Pediatric Hematology/Oncology. 36: 458-63. PMID 24276047 DOI: 10.1097/Mph.0B013E3182A8F58F |
0.376 |
|
| 2014 |
Zaky W, Dhall G, Ji L, Haley K, Allen J, Atlas M, Bertolone S, Cornelius A, Gardner S, Patel R, Pradhan K, Shen V, Thompson S, Torkildson J, Sposto R, et al. Intensive induction chemotherapy followed by myeloablative chemotherapy with autologous hematopoietic progenitor cell rescue for young children newly-diagnosed with central nervous system atypical teratoid/rhabdoid tumors: the Head Start III experience. Pediatric Blood & Cancer. 61: 95-101. PMID 23934933 DOI: 10.1002/Pbc.24648 |
0.453 |
|
| 2014 |
Whitlock J, dalla Pozza L, Goldberg JM, Silverman LB, Ziegler DS, Attarbaschi A, Brown P, Gardner RA, Gaynon PS, Hutchinson RJ, Marcus LJ, Messinger YH, Schultz KR, Vandergiessen J, Eckroth E, ... ... Sposto R, et al. Nelarabine in Combination with Etoposide and Cyclophosphamide Is Active in First Relapse of Childhood T-Acute Lymphocytic Leukemia (T-ALL) and T-Lymphoblastic Lymphoma (T-LL) Blood. 124: 795-795. DOI: 10.1182/Blood.V124.21.795.795 |
0.326 |
|
| 2014 |
Sun W, Gaynon PS, Sposto R, Bittencourt H, Place AE, Messinger YH, Fraser C, Dalla-Pozza L, Giessen Jvd, Eckroth E, Yang X, Liang G, Jones PA, Wayne AS, Cooper T. A Phase 1 Study of Azacitidine (AZA) in Combination with Fludarabine and Cytarabine in Relapse/Refractory Childhood Leukemia: A Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) Study Blood. 124: 3764-3764. DOI: 10.1182/Blood.V124.21.3764.3764 |
0.39 |
|
| 2014 |
Goldberg JM, Glade-Bender J, Sulis ML, Gardner RA, Pollard JA, Aquino V, Winick NJ, Bostrom BC, Fu C, Hutchinson RJ, Manley TJ, Mody R, Oesterheld J, Thomson B, Park JR, ... ... Sposto R, et al. A Phase I Dose Finding Study of Panobinostat in Children with Hematologic Malignancies: Initial Report of TACL Study T2009-012 in Children with Acute Leukemia Blood. 124: 3705-3705. DOI: 10.1182/Blood.V124.21.3705.3705 |
0.384 |
|
| 2014 |
Burke MJ, Brown P, Gore L, Sposto R, Bhojwani D, Chang BH, Dubois SG, Gaynon PS, Glade-Bender J, Heym KM, Sulis ML, Pollard JA, Verma A, Huynh V. Invasive Candida Infections in Pediatric Patients Treated on the Pilot Study of Decitabine and Vorinostat with Chemotherapy for Relapsed ALL: A Report from the Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) Consortium Blood. 124: 3650-3650. DOI: 10.1182/Blood.V124.21.3650.3650 |
0.382 |
|
| 2014 |
Sun W, Smith AM, Etan O, Sposto R, Wilkes JJ, Gardner RA, Minjun H, Pineros V, Olson E, Tan Y, Rheingold SR, Burke MJ, Wayne AS. The UK ALLR3 Chemotherapy Regimen for Relapsed/Refractory Acute Lymphoblastic Leukemia of Childhood: A Multi-Institutional Retrospective Study of Treatment Related Adverse Events Blood. 124: 3647-3647. DOI: 10.1182/Blood.V124.21.3647.3647 |
0.379 |
|
| 2014 |
Margol A, Gnanachandran J, Robison N, Hung L, Kennedy R, Vali M, Dhall G, Finlay J, Epstein A, Krieger M, Dorris K, Fouladi M, Gilles F, Judkins A, Sposto R, et al. Abstract B18: Presence of tumor-associated macrophages in SHH medulloblastoma Cancer Research. 74. DOI: 10.1158/1538-7445.Pedcan-B18 |
0.343 |
|
| 2014 |
Volchenboum SL, Andrade J, Barkauskas DA, Krailo M, Sposto R, Ranft A, Potratz J, Dirksen U, Triche TJ, Lawlor E. Abstract A72: Do prognostic gene signatures exist in Ewing sarcoma? A report from the Children's Oncology Group Cancer Research. 74. DOI: 10.1158/1538-7445.Pedcan-A72 |
0.388 |
|
| 2014 |
Solari V, Borriello L, Fernandez GE, Shimada H, Sposto R, Asgharzadeh S, Yates EA, Turnbull JE, Declerck YA. Abstract 3963: MYCN-dependent expression of sulfatase2 regulates neuroblastoma cell survival Cancer Research. 74: 3963-3963. DOI: 10.1158/1538-7445.Am2014-3963 |
0.319 |
|
| 2014 |
Finlay JL, Haley K, Vasquez L, Dhall G, Ji L, Sposto R, Gardner S. Progressive Decrease in Mortality of Post-Induction Marrow-Ablative Chemotherapy with Autologous Hematopoetic Cell Rescue for Young Children with Newly-Diagnosed Malignant Central Nervous System Tumors: The “Head Start” I-III (HSI-III) Trials, 1991-2009 Biology of Blood and Marrow Transplantation. 20. DOI: 10.1016/J.Bbmt.2013.12.100 |
0.387 |
|
| 2013 |
Xu Y, Sun J, Sheard MA, Tran HC, Wan Z, Liu WY, Asgharzadeh S, Sposto R, Wu HW, Seeger RC. Lenalidomide overcomes suppression of human natural killer cell anti-tumor functions by neuroblastoma microenvironment-associated IL-6 and TGFβ1. Cancer Immunology, Immunotherapy : Cii. 62: 1637-48. PMID 23982484 DOI: 10.1007/S00262-013-1466-Y |
0.33 |
|
| 2013 |
Venkatramani R, Malogolowkin M, Davidson TB, May W, Sposto R, Mascarenhas L. A phase I study of vincristine, irinotecan, temozolomide and bevacizumab (vitb) in pediatric patients with relapsed solid tumors. Plos One. 8: e68416. PMID 23894304 DOI: 10.1371/Journal.Pone.0068416 |
0.34 |
|
| 2013 |
Venkatramani R, Ji L, Lasky J, Haley K, Judkins A, Zhou S, Sposto R, Olshefski R, Garvin J, Tekautz T, Kennedy G, Rassekh SR, Moore T, Gardner S, Allen J, et al. Outcome of infants and young children with newly diagnosed ependymoma treated on the "Head Start" III prospective clinical trial. Journal of Neuro-Oncology. 113: 285-91. PMID 23508296 DOI: 10.1007/S11060-013-1111-9 |
0.43 |
|
| 2013 |
Mascarenhas L, Malogolowkin M, Armenian SH, Sposto R, Venkatramani R. A phase I study of oxaliplatin and doxorubicin in pediatric patients with relapsed or refractory extracranial non-hematopoietic solid tumors. Pediatric Blood & Cancer. 60: 1103-7. PMID 23335436 DOI: 10.1002/Pbc.24471 |
0.345 |
|
| 2013 |
Gerrard M, Waxman IM, Sposto R, Auperin A, Perkins SL, Goldman S, Harrison L, Pinkerton R, McCarthy K, Raphael M, Patte C, Cairo MS. Outcome and pathologic classification of children and adolescents with mediastinal large B-cell lymphoma treated with FAB/LMB96 mature B-NHL therapy. Blood. 121: 278-85. PMID 23149845 DOI: 10.1182/Blood-2012-04-422709 |
0.392 |
|
| 2013 |
Guerra J, Dhall G, Marachelian A, Castillo E, Malvar J, Sposto R, Wong K, Finlay JL. Marrow-ablative chemotherapy followed by tandem autologous hematopoietic cell transplantation (AuHCT) in pediatric patients with malignant brain tumors. Journal of Clinical Oncology. 31: 2049-2049. DOI: 10.1200/Jco.2013.31.15_Suppl.2049 |
0.406 |
|
| 2013 |
Marachelian A, Villablanca J, Asgharzadeh S, Liu WY, Liu B, Young S, Weiss BD, Katzenstein HM, Cohn SL, Baruchel S, Twist C, Granger M, Matthay KK, Malvar J, Sposto R, et al. Comparison of Taqman low density array (TLDA) five-gene assay for tumor cells in bone marrow and blood with histologic bone marrow examination and imaging for disease assessment and outcome in patients with recurrent/refractory neuroblastoma (NBL): A new approaches to neuroblastoma therapy (NANT) study. Journal of Clinical Oncology. 31: 10039-10039. DOI: 10.1200/Jco.2013.31.15_Suppl.10039 |
0.339 |
|
| 2013 |
Soni S, Abdel-Azim H, Eckroth E, Ccrc, Geissen Jvd, Ccrp, McManus MP, Nemecek ER, Sposto R, Thompson B, Woolfrey AE, Frangoul HA. Results Of a Phase I Study Of Clofarabine and 2 Gy Total Body Irradiation (TBI) As a Non-Myeloablative Preparative Regimen For Hematopoietic Stem Cell Transplantation (HSCT) In High Risk Children With Hematologic Malignancies: A Multi-Center TACL Study Blood. 122: 3286-3286. DOI: 10.1182/Blood.V122.21.3286.3286 |
0.383 |
|
| 2013 |
Erdreich-Epstein A, Ren X, Zhou H, Sposto R, Ji L, Pfister S, Kool M, Asgharzadeh S. Abstract 3825: Inhibitory effect of PID1 in medulloblastomas, gliomas and ATRT. Cancer Research. 73: 3825-3825. DOI: 10.1158/1538-7445.Am2013-3825 |
0.309 |
|
| 2012 |
Secola R, Azen C, Lewis MA, Pike N, Needleman J, Sposto R, Doering L. A crossover randomized prospective pilot study evaluating a central venous catheter team in reducing catheter-related bloodstream infections in pediatric oncology patients. Journal of Pediatric Oncology Nursing : Official Journal of the Association of Pediatric Oncology Nurses. 29: 307-15. PMID 23087249 DOI: 10.1177/1043454212461714 |
0.32 |
|
| 2012 |
Garvin JH, Selch MT, Holmes E, Berger MS, Finlay JL, Flannery A, Goldwein JW, Packer RJ, Rorke-Adams LB, Shiminski-Maher T, Sposto R, Stanley P, Tannous R, Pollack IF. Phase II study of pre-irradiation chemotherapy for childhood intracranial ependymoma. Children's Cancer Group protocol 9942: a report from the Children's Oncology Group. Pediatric Blood & Cancer. 59: 1183-9. PMID 22949057 DOI: 10.1002/Pbc.24274 |
0.437 |
|
| 2012 |
Asgharzadeh S, Salo JA, Ji L, Oberthuer A, Fischer M, Berthold F, Hadjidaniel M, Liu CW, Metelitsa LS, Pique-Regi R, Wakamatsu P, Villablanca JG, Kreissman SG, Matthay KK, Shimada H, ... ... Sposto R, et al. Clinical significance of tumor-associated inflammatory cells in metastatic neuroblastoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 3525-32. PMID 22927533 DOI: 10.1200/Jco.2011.40.9169 |
0.369 |
|
| 2012 |
Ater JL, Zhou T, Holmes E, Mazewski CM, Booth TN, Freyer DR, Lazarus KH, Packer RJ, Prados M, Sposto R, Vezina G, Wisoff JH, Pollack IF. Randomized study of two chemotherapy regimens for treatment of low-grade glioma in young children: a report from the Children's Oncology Group. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 2641-7. PMID 22665535 DOI: 10.1200/Jco.2011.36.6054 |
0.412 |
|
| 2012 |
Messinger YH, Gaynon PS, Sposto R, van der Giessen J, Eckroth E, Malvar J, Bostrom BC. Bortezomib with chemotherapy is highly active in advanced B-precursor acute lymphoblastic leukemia: Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) Study. Blood. 120: 285-90. PMID 22653976 DOI: 10.1182/Blood-2012-04-418640 |
0.371 |
|
| 2012 |
Wolden SL, Chen L, Kelly KM, Herzog P, Gilchrist GS, Thomson J, Sposto R, Kadin ME, Hutchinson RJ, Nachman J. Long-term results of CCG 5942: A randomized comparison of chemotherapy with and without radiotherapy for children with Hodgkin's lymphoma - A report from the Children's Oncology Group Journal of Clinical Oncology. 30: 3174-3180. PMID 22649136 DOI: 10.1200/Jco.2011.41.1819 |
0.438 |
|
| 2012 |
Marachelian A, Shimada H, Sano H, Jackson H, Stein J, Sposto R, Matthay KK, Baker D, Villablanca JG. The significance of serial histopathology in a residual mass for outcome of intermediate risk stage 3 neuroblastoma. Pediatric Blood & Cancer. 58: 675-81. PMID 22493777 DOI: 10.1002/Pbc.23250 |
0.351 |
|
| 2012 |
Cairo MS, Sposto R, Gerrard M, Auperin A, Goldman SC, Harrison L, Pinkerton R, Raphael M, McCarthy K, Perkins SL, Patte C. Advanced stage, increased lactate dehydrogenase, and primary site, but not adolescent age (≥ 15 years), are associated with an increased risk of treatment failure in children and adolescents with mature B-cell non-Hodgkin's lymphoma: results of the FAB LMB 96 study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 387-93. PMID 22215753 DOI: 10.1200/Jco.2010.33.3369 |
0.367 |
|
| 2012 |
Lones MA, Raphael M, McCarthy K, Wotherspoon A, Terrier-Lacombe MJ, Ramsay AD, Maclennan K, Cairo MS, Gerrard M, Michon J, Patte C, Pinkerton R, Sender L, Auperin A, Sposto R, et al. Primary follicular lymphoma of the testis in children and adolescents. Journal of Pediatric Hematology/Oncology. 34: 68-71. PMID 22215099 DOI: 10.1097/Mph.0B013E31820E4636 |
0.385 |
|
| 2012 |
Ruccione KS, Mudambi K, Sposto R, Fridey J, Ghazarossian S, Freyer DR. Association of projected transfusional iron burden with treatment intensity in childhood cancer survivors. Pediatric Blood & Cancer. 59: 697-702. PMID 22190481 DOI: 10.1002/Pbc.24046 |
0.325 |
|
| 2012 |
Venkatramani R, Wang L, Malvar J, Dias D, Sposto R, Malogolowkin MH, Mascarenhas L. Tumor necrosis predicts survival following neo-adjuvant chemotherapy for hepatoblastoma. Pediatric Blood & Cancer. 59: 493-8. PMID 22190448 DOI: 10.1002/Pbc.24038 |
0.406 |
|
| 2012 |
Bertelsen C, Ji L, Russell CA, Spicer DV, Garcia A, Sposto R, Tripathy D. Efficacy of low-dose capecitabine in metastatic breast cancer. Journal of Clinical Oncology. 30: 1065-1065. DOI: 10.1200/Jco.2012.30.15_Suppl.1065 |
0.358 |
|
| 2012 |
Cooper T, Sposto R, Cassar J, Eckroth E, Malvar J, Gaynon P, Dubois S, Chang BH, Gore L, August KJ, Thomson B, Gammon G, Magoon D, Annesley CE, Brown P. A Phase I Study Of AC220 (Quizartinib) In Combination With Cytarabine and Etoposide In Relapsed/Refractory Childhood ALL and AML: A Therapeutic Advances In Childhood Leukemia & Lymphoma (TACL) Study Blood. 122: 624-624. DOI: 10.1182/Blood.V122.21.624.624 |
0.371 |
|
| 2012 |
Vigen CL, Gomez SL, Sposto R, Lu Y, Kwan ML, John EM, Monroe KR, Keegan TH, Shariff-Marco S, Kurian AW, Cheng I, Caan BJ, Lee VS, Roh JM, Sullivan-Halley J, et al. Abstract A04: The California Breast Cancer Survivorship Consortium (CBCSC): Prognostic factors associated with racial/ethnic differences in breast cancer survival Cancer Prevention Research. 5: A04-A04. DOI: 10.1158/1940-6207.Prev-12-A04 |
0.304 |
|
| 2012 |
Erdreich-Epstein A, Ren X, Zhou H, Schur M, Ji L, Sposto R, Asgharzadeh S. Abstract 4334: Expression of PID1 correlates with PFS in pediatric medulloblastomas and negatively impacts growth of medulloblastoma, glioblastoma and AT/RT brain tumor cell lines Cancer Research. 72: 4334-4334. DOI: 10.1158/1538-7445.Am2012-4334 |
0.337 |
|
| 2012 |
Hadjidaniel MD, Muthugounder S, Hung L, Sheard M, Bonne-Grardel S, Gnanachandran J, Iwakura H, Akamizu T, Sposto R, Shimada H, Asgharzadeh S. Abstract 383: Interleukin-6 producing tumor associated macrophages (TAMs) increase MYC expression and promote tumor growth in a novel murine neuroblastoma model Cancer Research. 72: 383-383. DOI: 10.1158/1538-7445.Am2012-383 |
0.31 |
|
| 2011 |
Klobocista M, Yessaian AA, Morrow CP, Muderspach L, Pham H, Lin YG, Sposto R, Roman L. The role of adjuvant chemotherapy in early-stage high-grade uterine leiomyosarcoma: A retrospective review. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: e15500. PMID 28023859 DOI: 10.1200/Jco.2011.29.15_Suppl.E15500 |
0.337 |
|
| 2011 |
Dhall G, Ji L, Haley K, Grimm JP, Gilles FH, Gardner SL, Allen JC, Cornelius A, Pradhan KR, Garvin JH, Olshefski RS, Hukin J, Comito M, Goldman S, Thompson SJ, ... ... Sposto R, et al. Outcome of infants and young children with newly diagnosed medulloblastoma treated on Head Start III protocol. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 2011. PMID 28023858 DOI: 10.1200/Jco.2011.29.15_Suppl.2011 |
0.395 |
|
| 2011 |
Davidson TB, Ji L, Haley K, Dhall G, Grimm JP, Gilles FH, Gardner SL, Allen JC, Bedros AA, Etzl MM, Olshefski RS, Cornelius A, Torkildson J, Kennedy GA, Fangusaro JR, ... ... Sposto R, et al. Outcome of Head Start III multinational protocol for newly diagnosed central nervous system (CNS) primitive neuroectodermal tumors (pnet) of young children. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 9519. PMID 28019815 DOI: 10.1200/Jco.2011.29.15_Suppl.9519 |
0.379 |
|
| 2011 |
Sposto R, Groshen S. A wide-spectrum paired comparison of the properties of the Rolling 6 and 3+3 Phase I study designs. Contemporary Clinical Trials. 32: 694-703. PMID 21554993 DOI: 10.1016/J.Cct.2011.04.009 |
0.318 |
|
| 2011 |
O'Neil S, Ji L, Buranahirun C, Azoff J, Dhall G, Khatua S, Patel S, Panigrahy A, Borchert M, Sposto R, Finlay J. Neurocognitive outcomes in pediatric and adolescent patients with central nervous system germinoma treated with a strategy of chemotherapy followed by reduced-dose and volume irradiation. Pediatric Blood & Cancer. 57: 669-73. PMID 21495164 DOI: 10.1002/Pbc.23146 |
0.349 |
|
| 2011 |
Wisoff JH, Sanford RA, Heier LA, Sposto R, Burger PC, Yates AJ, Holmes EJ, Kun LE. Primary neurosurgery for pediatric low-grade gliomas: a prospective multi-institutional study from the Children's Oncology Group. Neurosurgery. 68: 1548-54; discussion . PMID 21368693 DOI: 10.1227/Neu.0B013E318214A66E |
0.4 |
|
| 2011 |
Kelly KM, Sposto R, Hutchinson R, Massey V, McCarten K, Perkins S, Lones M, Villaluna D, Weiner M. BEACOPP chemotherapy is a highly effective regimen in children and adolescents with high-risk Hodgkin lymphoma: a report from the Children's Oncology Group. Blood. 117: 2596-603. PMID 21079154 DOI: 10.1182/Blood-2010-05-285379 |
0.429 |
|
| 2011 |
Cooper A, van Doorninck J, Ji L, Russell D, Ladanyi M, Shimada H, Krailo M, Womer RB, Hsu JH, Thomas D, Triche TJ, Sposto R, Lawlor ER. Ewing tumors that do not overexpress BMI-1 are a distinct molecular subclass with variant biology: a report from the Children's Oncology Group. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 56-66. PMID 21047978 DOI: 10.1158/1078-0432.Ccr-10-1417 |
0.355 |
|
| 2011 |
Quach A, Ji L, Mishra V, Sznewajs A, Veatch J, Huberty J, Franc B, Sposto R, Groshen S, Wei D, Fitzgerald P, Maris JM, Yanik G, Hawkins RA, Villablanca JG, et al. Thyroid and hepatic function after high-dose 131 I-metaiodobenzylguanidine (131 I-MIBG) therapy for neuroblastoma. Pediatric Blood & Cancer. 56: 191-201. PMID 20830775 DOI: 10.1002/Pbc.22767 |
0.326 |
|
| 2011 |
Orgel E, Sposto R, Malvar J, Seibel NL, Ladas EJ, Gaynon P, Freyer DR. Extremes of Weight Are Associated with Increased Treatment-Related Toxicity in High-Risk Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group, Blood. 118: 3574-3574. DOI: 10.1182/Blood.V118.21.3574.3574 |
0.393 |
|
| 2011 |
Messinger YH, Gaynon P, Sposto R, Giessen Jvd, Eckroth E, Malvar J, Bostrom BC. Bortezomib Combined with VXLD Chemotherapy Is Highly Effective In Advanced B-Lineage Acute Lymphoblastic Leukemia Allowing Early Study Termination Due to Efficacy. A Therapeutic Advances in Childhood Leukemia (TACL) Consortium Phase II Study Blood. 118: 251-251. DOI: 10.1182/Blood.V118.21.251.251 |
0.397 |
|
| 2011 |
Pugh TJ, Lawrence M, Sougnez C, Getz G, Attiyeh E, Hogarty M, Diskin S, Yael M, Diamond M, Asgharzadeh S, Sposto R, Wei JS, Badgett T, London WB, Gastier-Foster J, et al. Abstract 4756: Exome sequencing of 81 neuroblastomas identifies a wide diversity of somatic mutation Cancer Research. 71: 4756-4756. DOI: 10.1158/1538-7445.Am2011-4756 |
0.307 |
|
| 2010 |
Gorman MF, Ji L, Ko RH, Barnette P, Bostrom B, Hutchinson R, Raetz E, Seibel NL, Twist CJ, Eckroth E, Sposto R, Gaynon PS, Loh ML. Outcome for children treated for relapsed or refractory acute myelogenous leukemia (rAML): a Therapeutic Advances in Childhood Leukemia (TACL) Consortium study. Pediatric Blood & Cancer. 55: 421-9. PMID 20658611 DOI: 10.1002/Pbc.22612 |
0.412 |
|
| 2010 |
Messinger Y, Gaynon P, Raetz E, Hutchinson R, Dubois S, Glade-Bender J, Sposto R, van der Giessen J, Eckroth E, Bostrom BC. Phase I study of bortezomib combined with chemotherapy in children with relapsed childhood acute lymphoblastic leukemia (ALL): a report from the therapeutic advances in childhood leukemia (TACL) consortium. Pediatric Blood & Cancer. 55: 254-9. PMID 20582937 DOI: 10.1002/Pbc.22456 |
0.392 |
|
| 2010 |
Sposto R. Commentary on paper, 'cancer survival analysis'. Surgical Oncology. 19: 59-60; discussion 61. PMID 20471825 DOI: 10.1016/J.Suronc.2010.04.002 |
0.306 |
|
| 2010 |
Wells EM, Khademian ZP, Walsh KS, Vezina G, Sposto R, Keating RF, Packer RJ. Postoperative cerebellar mutism syndrome following treatment of medulloblastoma: neuroradiographic features and origin. Journal of Neurosurgery. Pediatrics. 5: 329-34. PMID 20367335 DOI: 10.3171/2009.11.Peds09131 |
0.312 |
|
| 2010 |
van Doorninck JA, Ji L, Schaub B, Shimada H, Wing MR, Krailo MD, Lessnick SL, Marina N, Triche TJ, Sposto R, Womer RB, Lawlor ER. Current treatment protocols have eliminated the prognostic advantage of type 1 fusions in Ewing sarcoma: a report from the Children's Oncology Group. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 28: 1989-94. PMID 20308669 DOI: 10.1200/Jco.2009.24.5845 |
0.384 |
|
| 2010 |
Khatua S, Dhall G, O'Neil S, Jubran R, Villablanca JG, Marachelian A, Nastia A, Lavey R, Olch AJ, Gonzalez I, Gilles F, Nelson M, Panigrahy A, McComb G, Krieger M, ... ... Sposto R, et al. Treatment of primary CNS germinomatous germ cell tumors with chemotherapy prior to reduced dose whole ventricular and local boost irradiation. Pediatric Blood & Cancer. 55: 42-6. PMID 20222020 DOI: 10.1002/Pbc.22468 |
0.406 |
|
| 2010 |
Serowka K, Chiu Y, Gonzalez I, Gilles F, McComb G, Krieger M, Dhall G, Britt B, Ji L, Sposto R, Finlay JL. Central nervous system (CNS) tumors in the first six months of life: the Children's Hospital Los Angeles experience, 1979-2005. Pediatric Hematology and Oncology. 27: 90-102. PMID 20201690 DOI: 10.3109/08880010903447342 |
0.41 |
|
| 2010 |
Song HR, Gonzalez-Gomez I, Suh GS, Commins DL, Sposto R, Gilles FH, Deneen B, Erdreich-Epstein A. Nuclear factor IA is expressed in astrocytomas and is associated with improved survival. Neuro-Oncology. 12: 122-32. PMID 20150379 DOI: 10.1093/Neuonc/Nop044 |
0.362 |
|
| 2010 |
Horton TM, Sposto R, Brown P, Reynolds CP, Hunger SP, Winick NJ, Raetz EA, Carroll WL, Arceci RJ, Borowitz MJ, Gaynon PS, Gore L, Jeha S, Maurer BJ, Siegel SE, et al. Toxicity assessment of molecularly targeted drugs incorporated into multiagent chemotherapy regimens for pediatric acute lymphocytic leukemia (ALL): review from an international consensus conference. Pediatric Blood & Cancer. 54: 872-8. PMID 20127846 DOI: 10.1002/Pbc.22414 |
0.343 |
|
| 2010 |
Ko RH, Ji L, Barnette P, Bostrom B, Hutchinson R, Raetz E, Seibel NL, Twist CJ, Eckroth E, Sposto R, Gaynon PS, Loh ML. Outcome of patients treated for relapsed or refractory acute lymphoblastic leukemia: a Therapeutic Advances in Childhood Leukemia Consortium study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 28: 648-54. PMID 19841326 DOI: 10.1200/Jco.2009.22.2950 |
0.41 |
|
| 2010 |
Mascarenhas L, Armenian S, Harrington JL, Mahmoud H, Sposto R, Malogolowkin MH. Phase I trial of oxaliplatin and doxorubicin in children and adolescents with recurrent solid tumors. Journal of Clinical Oncology. 28: 9543-9543. DOI: 10.1200/Jco.2010.28.15_Suppl.9543 |
0.326 |
|
| 2010 |
Meeske KA, Ji L, Butturini A, Freyer DR, Gaynon PS, Ruccione K, Sposto R, Seibel NL, Siegel SE. Childhood cancer: Do females experience more acute toxicities than males? A report from the Children's Oncology Group. Journal of Clinical Oncology. 28: 9515-9515. DOI: 10.1200/Jco.2010.28.15_Suppl.9515 |
0.338 |
|
| 2010 |
Asgharzadeh S, Ji L, Sposto R, Attiyeh E, Tu Y, Hadjidaniel M, Hogarty MD, London WB, Gastier-Foster J, Wei J, Guo X, Gerhard DS, Smith MA, Khan J, Maris JM, et al. Abstract 5249: Identification of genome-wide alternative splicing events in high-riskMYCNamplified neuroblastomas Cancer Research. 70: 5249-5249. DOI: 10.1158/1538-7445.Am10-5249 |
0.319 |
|
| 2010 |
Scannell CA, Abdueva D, Ji L, Levetzow Cv, Sposto R, Triche TJ, Lawlor ER. Abstract 4640: High expression of the stem cell marker LGR5 is associated with a poor clinical outcome in patients with Ewing's sarcoma Cancer Research. 70: 4640-4640. DOI: 10.1158/1538-7445.Am10-4640 |
0.343 |
|
| 2009 |
Schwartz CL, Constine LS, Villaluna D, London WB, Hutchison RE, Sposto R, Lipshultz SE, Turner CS, deAlarcon PA, Chauvenet A. A risk-adapted, response-based approach using ABVE-PC for children and adolescents with intermediate- and high-risk Hodgkin lymphoma: the results of P9425. Blood. 114: 2051-9. PMID 19584400 DOI: 10.1182/Blood-2008-10-184143 |
0.388 |
|
| 2009 |
Meeske KA, Siegel SE, Gilsanz V, Bernstein L, Nelson MB, Sposto R, Weaver FA, Lavey RS, Mack MP, Nelson MD. Premature carotid artery disease in pediatric cancer survivors treated with neck irradiation. Pediatric Blood & Cancer. 53: 615-21. PMID 19533651 DOI: 10.1002/Pbc.22111 |
0.306 |
|
| 2009 |
Sposto R, Gaynon PS. An adjustment for patient heterogeneity in the design of two-stage phase II trials. Statistics in Medicine. 28: 2566-79. PMID 19521973 DOI: 10.1002/Sim.3624 |
0.301 |
|
| 2009 |
Song L, Asgharzadeh S, Salo J, Engell K, Wu HW, Sposto R, Ara T, Silverman AM, DeClerck YA, Seeger RC, Metelitsa LS. Valpha24-invariant NKT cells mediate antitumor activity via killing of tumor-associated macrophages. The Journal of Clinical Investigation. 119: 1524-36. PMID 19411762 DOI: 10.1172/Jci37869 |
0.319 |
|
| 2009 |
Allen J, Donahue B, Mehta M, Miller DC, Rorke LB, Jakacki R, Robertson P, Sposto R, Holmes E, Vezina G, Muraszko K, Puccetti D, Prados M, Chan KW. A phase II study of preradiotherapy chemotherapy followed by hyperfractionated radiotherapy for newly diagnosed high-risk medulloblastoma/primitive neuroectodermal tumor: a report from the Children's Oncology Group (CCG 9931). International Journal of Radiation Oncology, Biology, Physics. 74: 1006-11. PMID 19356859 DOI: 10.1016/J.Ijrobp.2008.09.019 |
0.437 |
|
| 2009 |
Poirel HA, Cairo MS, Heerema NA, Swansbury J, Aupérin A, Launay E, Sanger WG, Talley P, Perkins SL, Raphaël M, McCarthy K, Sposto R, Gerrard M, Bernheim A, Patte C, et al. Specific cytogenetic abnormalities are associated with a significantly inferior outcome in children and adolescents with mature B-cell non-Hodgkin's lymphoma: results of the FAB/LMB 96 international study. Leukemia. 23: 323-31. PMID 19020548 DOI: 10.1038/Leu.2008.312 |
0.337 |
|
| 2009 |
Lowe EJ, Sposto R, Perkins SL, Gross TG, Finlay J, Zwick D, Abromowitch M. Intensive chemotherapy for systemic anaplastic large cell lymphoma in children and adolescents: final results of Children's Cancer Group Study 5941. Pediatric Blood & Cancer. 52: 335-9. PMID 18985718 DOI: 10.1002/Pbc.21817 |
0.425 |
|
| 2008 |
Gorman M, Ko R, Ji L, Sposto R, Eckroth E, Gaynon PS, Loh M. Retrospective analysis of children treated for relapsed acute myelogenous leukemia (rAML): A report from the Therapeutic Advances in Childhood Leukemia (TACL) Consortium. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 10042. PMID 27951297 DOI: 10.1200/Jco.2008.26.15_Suppl.10042 |
0.384 |
|
| 2008 |
Armenian SH, Sun CL, Francisco L, Steinberger J, Kurian S, Wong FL, Sharp J, Sposto R, Forman SJ, Bhatia S. Late congestive heart failure after hematopoietic cell transplantation. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 5537-43. PMID 18809605 DOI: 10.1200/Jco.2008.17.7428 |
0.322 |
|
| 2008 |
Kim A, Ji L, Balmaceda C, Diez B, Kellie SJ, Dunkel IJ, Gardner SL, Sposto R, Finlay JL. The prognostic value of tumor markers in newly diagnosed patients with primary central nervous system germ cell tumors. Pediatric Blood & Cancer. 51: 768-73. PMID 18802946 DOI: 10.1002/Pbc.21741 |
0.391 |
|
| 2008 |
Abromowitch M, Sposto R, Perkins S, Zwick D, Siegel S, Finlay J, Cairo MS. Shortened intensified multi-agent chemotherapy and non-cross resistant maintenance therapy for advanced lymphoblastic lymphoma in children and adolescents: report from the Children's Oncology Group. British Journal of Haematology. 143: 261-7. PMID 18759768 DOI: 10.1111/J.1365-2141.2008.07320.X |
0.383 |
|
| 2008 |
Miles RR, Raphael M, McCarthy K, Wotherspoon A, Lones MA, Terrier-Lacombe MJ, Patte C, Gerrard M, Auperin A, Sposto R, Davenport V, Cairo MS, Perkins SL. Pediatric diffuse large B-cell lymphoma demonstrates a high proliferation index, frequent c-Myc protein expression, and a high incidence of germinal center subtype: Report of the French-American-British (FAB) international study group. Pediatric Blood & Cancer. 51: 369-74. PMID 18493992 DOI: 10.1002/Pbc.21619 |
0.343 |
|
| 2008 |
Gerrard M, Cairo MS, Weston C, Auperin A, Pinkerton R, Lambilliote A, Sposto R, McCarthy K, Lacombe MJ, Perkins SL, Patte C. Excellent survival following two courses of COPAD chemotherapy in children and adolescents with resected localized B-cell non-Hodgkin's lymphoma: results of the FAB/LMB 96 international study. British Journal of Haematology. 141: 840-7. PMID 18371107 DOI: 10.1111/J.1365-2141.2008.07144.X |
0.407 |
|
| 2008 |
Dhall G, Grodman H, Ji L, Sands S, Gardner S, Dunkel IJ, McCowage GB, Diez B, Allen JC, Gopalan A, Cornelius AS, Termuhlen A, Abromowitch M, Sposto R, Finlay JL. Outcome of children less than three years old at diagnosis with non-metastatic medulloblastoma treated with chemotherapy on the "Head Start" I and II protocols. Pediatric Blood & Cancer. 50: 1169-75. PMID 18293379 DOI: 10.1002/Pbc.21525 |
0.379 |
|
| 2008 |
Panigrahy A, Nelson MD, Finlay JL, Sposto R, Krieger MD, Gilles FH, Blüml S. Metabolism of diffuse intrinsic brainstem gliomas in children. Neuro-Oncology. 10: 32-44. PMID 18003889 DOI: 10.1215/15228517-2007-042 |
0.3 |
|
| 2008 |
Fangusaro J, Finlay J, Sposto R, Ji L, Saly M, Zacharoulis S, Asgharzadeh S, Abromowitch M, Olshefski R, Halpern S, Dubowy R, Comito M, Diez B, Kellie S, Hukin J, et al. Intensive chemotherapy followed by consolidative myeloablative chemotherapy with autologous hematopoietic cell rescue (AuHCR) in young children with newly diagnosed supratentorial primitive neuroectodermal tumors (sPNETs): report of the Head Start I and II experience. Pediatric Blood & Cancer. 50: 312-8. PMID 17668858 DOI: 10.1002/Pbc.21307 |
0.433 |
|
| 2008 |
Zacharoulis S, Ji L, Pollack IF, Duffner P, Geyer R, Grill J, Schild S, Jaing TH, Massimino M, Finlay J, Sposto R. Metastatic ependymoma: a multi-institutional retrospective analysis of prognostic factors. Pediatric Blood & Cancer. 50: 231-5. PMID 17610266 DOI: 10.1002/Pbc.21276 |
0.397 |
|
| 2007 |
Song L, Ara T, Wu HW, Woo CW, Reynolds CP, Seeger RC, DeClerck YA, Thiele CJ, Sposto R, Metelitsa LS. Oncogene MYCN regulates localization of NKT cells to the site of disease in neuroblastoma. The Journal of Clinical Investigation. 117: 2702-12. PMID 17710228 DOI: 10.1172/Jci30751 |
0.316 |
|
| 2007 |
Teot LA, Sposto R, Khayat A, Qualman S, Reaman G, Parham D. The problems and promise of central pathology review: development of a standardized procedure for the Children's Oncology Group. Pediatric and Developmental Pathology : the Official Journal of the Society For Pediatric Pathology and the Paediatric Pathology Society. 10: 199-207. PMID 17535088 DOI: 10.2350/06-06-0121.1 |
0.305 |
|
| 2007 |
Sposto R, London WB, Alonzo TA. Criteria for optimizing prognostic risk groups in pediatric cancer: analysis of data from the Children's Oncology Group. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 25: 2070-7. PMID 17513812 DOI: 10.1200/Jco.2006.09.1983 |
0.39 |
|
| 2007 |
Tebbi CK, London WB, Friedman D, Villaluna D, De Alarcon PA, Constine LS, Mendenhall NP, Sposto R, Chauvenet A, Schwartz CL. Dexrazoxane-associated risk for acute myeloid leukemia/myelodysplastic syndrome and other secondary malignancies in pediatric Hodgkin's disease. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 25: 493-500. PMID 17290056 DOI: 10.1200/Jco.2005.02.3879 |
0.311 |
|
| 2007 |
Lones MA, Heerema NA, Le Beau MM, Sposto R, Perkins SL, Kadin ME, Kjeldsberg CR, Meadows A, Siegel S, Buckley J, Abromowitch M, Kersey J, Bergeron S, Cairo MS, Sanger WG. Chromosome abnormalities in advanced stage lymphoblastic lymphoma of children and adolescents: a report from CCG-E08 Cancer Genetics and Cytogenetics. 172: 1-11. PMID 17175373 DOI: 10.1016/J.Cancergencyto.2006.07.011 |
0.345 |
|
| 2007 |
Cairo MS, Gerrard M, Sposto R, Auperin A, Pinkerton CR, Michon J, Weston C, Perkins SL, Raphael M, McCarthy K, Patte C. Results of a randomized international study of high-risk central nervous system B non-Hodgkin lymphoma and B acute lymphoblastic leukemia in children and adolescents Blood. 109: 2736-2743. PMID 17138821 DOI: 10.1182/Blood-2006-07-036665 |
0.382 |
|
| 2007 |
Patte C, Auperin A, Gerrard M, Michon J, Pinkerton R, Sposto R, Weston C, Raphael M, Perkins SL, McCarthy K, Cairo MS. Results of the randomized international FAB/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: It is possible to reduce treatment for the early responding patients Blood. 109: 2773-2780. PMID 17132719 DOI: 10.1182/Blood-2006-07-036673 |
0.405 |
|
| 2007 |
Zacharoulis S, Levy A, Chi SN, Gardner S, Rosenblum M, Miller DC, Dunkel I, Diez B, Sposto R, Ji L, Asgharzadeh S, Hukin J, Belasco J, Dubowy R, Kellie S, et al. Outcome for young children newly diagnosed with ependymoma, treated with intensive induction chemotherapy followed by myeloablative chemotherapy and autologous stem cell rescue. Pediatric Blood & Cancer. 49: 34-40. PMID 16874765 DOI: 10.1002/Pbc.20935 |
0.437 |
|
| 2007 |
Chi S, Gardner S, Ji LY, Sposto R, Dhall G, Finlay J. Newly diagnosed high-risk malignant brain tumors with leptomeningeal dissemination in young children: A final update on Head Start II Regimen A2 intensified with high-dose methotrexate Journal of Clinical Oncology. 25: 9552-9552. DOI: 10.1200/Jco.2007.25.18_Suppl.9552 |
0.348 |
|
| 2007 |
Dhall G, Grodman H, Ji L, Sands S, Gardner S, Allen J, Sposto R, Finlay J. Outcome of children less than three years old at diagnosis with non-metastatic medulloblastoma treated with chemotherapy on the "Head Start" I and II protocols: Final report Journal of Clinical Oncology. 25: 9507-9507. DOI: 10.1200/Jco.2007.25.18_Suppl.9507 |
0.372 |
|
| 2006 |
Robertson PL, Muraszko KM, Holmes EJ, Sposto R, Packer RJ, Gajjar A, Dias MS, Allen JC. Incidence and severity of postoperative cerebellar mutism syndrome in children with medulloblastoma: A prospective study by the Children's Oncology Group Journal of Neurosurgery. 105: 444-451. PMID 17184075 DOI: 10.3171/Ped.2006.105.6.444 |
0.366 |
|
| 2006 |
Lones MA, Heerema NA, Le Beau MM, Perkins SL, Kadin ME, Kjeldsberg CR, Sposto R, Meadows A, Siegel S, Buckley J, Finlay J, Abromowitch M, Cairo MS, Sanger WG. Complex secondary chromosome abnormalities in advanced stage anaplastic large cell lymphoma of children and adolescents: a report from CCG-E08. Cancer Genetics and Cytogenetics. 171: 89-96. PMID 17116485 DOI: 10.1016/J.Cancergencyto.2006.04.019 |
0.357 |
|
| 2006 |
Lones MA, Raphael M, Perkins SL, Wotherspoon A, Auperin A, Terrier-Lacombe MJ, Sposto R, Weston C, Gerrard M, Patte C, Cairo MS, McCarthy K. Mature B-Cell Lymphoma in children and adolescents: International group pathologist consensus correlates with histology technical quality Journal of Pediatric Hematology/Oncology. 28: 568-574. PMID 17006262 DOI: 10.1097/01.Mph.0000212980.67114.A5 |
0.357 |
|
| 2006 |
Asgharzadeh S, Pique-Regi R, Sposto R, Wang H, Yang Y, Shimada H, Matthay K, Buckley J, Ortega A, Seeger RC. Prognostic significance of gene expression profiles of metastatic neuroblastomas lacking MYCN gene amplification. Journal of the National Cancer Institute. 98: 1193-203. PMID 16954472 DOI: 10.1093/Jnci/Djj330 |
0.359 |
|
| 2006 |
Packer RJ, Gajjar A, Vezina G, Rorke-Adams L, Burger PC, Robertson PL, Bayer L, LaFond D, Donahue BR, Marymont MH, Muraszko K, Langston J, Sposto R. Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 24: 4202-8. PMID 16943538 DOI: 10.1200/Jco.2006.06.4980 |
0.385 |
|
| 2006 |
Sposto R, Raetz EA, Reynolds CP, Gaynon PS. Multi-Agent Phase I Trials in Childhood Acute Lymphoblastic Leukemia (ALL). Blood. 108: 4528-4528. DOI: 10.1182/Blood.V108.11.4528.4528 |
0.34 |
|
| 2006 |
Perentesis JP, Villaluna D, Davies SM, Zhai X, Radloff GA, Weiner MA, Sposto R, Kelly KM. Pharmacogenetic Predictors of Toxicity in Dose-Intensive Therapy for Pediatric Advanced-Stage Hodgkin’s Lymphoma. Blood. 108: 100-100. DOI: 10.1182/Blood.V108.11.100.100 |
0.38 |
|
| 2005 |
Sposto R, Kelly KM, Villaluna D, Gilman E, Pfistner B, Diehl V. A comparison of toxicity and outcome following BEACOPP therapy in adolescents and young adults with Hodgkin's disease (HD) by pediatric and adult oncology cooperative groups. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 6599. PMID 27943746 DOI: 10.1200/Jco.2005.23.16_Suppl.6599 |
0.341 |
|
| 2005 |
MacDonald TJ, Arenson EB, Ater J, Sposto R, Bevan HE, Bruner J, Deutsch M, Kurczynski E, Luerssen T, McGuire-Cullen P, O'Brien R, Shah N, Steinbok P, Strain J, Thomson J, et al. Phase II study of high-dose chemotherapy before radiation in children with newly diagnosed high-grade astrocytoma: final analysis of Children's Cancer Group Study 9933. Cancer. 104: 2862-71. PMID 16315242 DOI: 10.1002/Cncr.21593 |
0.398 |
|
| 2005 |
Geyer JR, Sposto R, Jennings M, Boyett JM, Axtell RA, Breiger D, Broxson E, Donahue B, Finlay JL, Goldwein JW, Heier LA, Johnson D, Mazewski C, Miller DC, Packer R, et al. Multiagent chemotherapy and deferred radiotherapy in infants with malignant brain tumors: a report from the Children's Cancer Group. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 7621-31. PMID 16234523 DOI: 10.1200/Jco.2005.09.095 |
0.423 |
|
| 2005 |
Hiotis K, Ye W, Sposto R, Skinner KA. Predictors of breast conservation therapy: size is not all that matters. Cancer. 103: 892-9. PMID 15641031 DOI: 10.1002/Cncr.20853 |
0.307 |
|
| 2005 |
Nachman J, Sposto R, Herzog P, Wolden S, Kadin M. Low dose involved field radiation (IFRT) or no further treatment following complete response to initial chemotherapy in young adult (YA) patients 16–21 years of age with Hodgkin’s disease (HD): The Children’s Cancer Group (CCG) Experience Journal of Clinical Oncology. 23: 8513-8513. DOI: 10.1200/Jco.2005.23.16_Suppl.8513 |
0.401 |
|
| 2005 |
Goldman S, Gerrard M, Sposto R, Davenport G, Auperin A, Pinkerton R, Michon J, Weston C, Perkins SL, Raphael M, McCarthy K, Patte C, Cairo MS. Excellent Results in Children and Adolescents with Isolated Mature B-Acute Lymphoblastic Leukemia (B-ALL) (Burkitt): Report from the French-American-British (FAB) International LMB Study FAB/LMB96. Blood. 106: 234-234. DOI: 10.1182/Blood.V106.11.234.234 |
0.361 |
|
| 2005 |
Chen A, Hess A, Gardner S, Trippett T, Alarcon Pd, Guillerman R, Hogan S, Mitchell J, Gamis A, Massey V, Constine LS, Villaluna D, Sposto R, Schwartz C. Cyclosporine, Interferon-γ , and Interleukin-2 Immunotherapy Is Tolerable and Induces Autoreactivity in Patients with Recurrent/Refractory Hodgkin Disease Undergoing Autologous Stem Cell Transplantation with BEAM: A COG Study. Blood. 106: 2087-2087. DOI: 10.1182/Blood.V106.11.2087.2087 |
0.386 |
|
| 2004 |
Lones MA, Sanger WG, Le Beau MM, Heerema NA, Sposto R, Perkins SL, Buckley J, Kadin ME, Kjeldsberg CR, Meadows A, Siegel S, Finlay J, Bergeron S, Cairo MS. Chromosome abnormalities may correlate with prognosis in Burkitt/Burkitt-like lymphomas of children and adolescents: a report from Children's Cancer Group Study CCG-E08. Journal of Pediatric Hematology/Oncology. 26: 169-78. PMID 15125609 DOI: 10.1097/00043426-200403000-00006 |
0.332 |
|
| 2004 |
Broniscer A, Nicolaides TP, Dunkel IJ, Gardner SL, Johnson J, Allen JC, Sposto R, Finlay JL. High-dose chemotherapy with autologous stem-cell rescue in the treatment of patients with recurrent non-cerebellar primitive neuroectodermal tumors. Pediatric Blood & Cancer. 42: 261-7. PMID 14752864 DOI: 10.1002/Pbc.10369 |
0.402 |
|
| 2004 |
Trippett T, Alarcon PD, London W, Sposto R, Chen A, Gardner S, Schwartz C. AHOD00P1, a Pilot Study of Re-Induction Chemotherapy with Ifosfamide, and Vinorelbine (IV) in Children with Refractory/Relapsed Hodgkin Disease. Blood. 104: 2496-2496. DOI: 10.1182/Blood.V104.11.2496.2496 |
0.385 |
|
| 2003 |
Cairo MS, Sposto R, Perkins SL, Meadows AT, Hoover-Regan ML, Anderson JR, Siegel SE, Lones MA, Tedeschi-Blok N, Kadin ME, Kjeldsberg CR, Wilson JF, Sanger W, Morris E, Krailo MD, et al. Burkitt's and Burkitt-like lymphoma in children and adolescents: a review of the Children's Cancer Group experience. British Journal of Haematology. 120: 660-70. PMID 12588354 DOI: 10.1046/J.1365-2141.2003.04134.X |
0.376 |
|
| 2003 |
Sabesan V, Cairo MS, Lones MA, Perkins SL, Morris E, Sposto R, De Ven CV, Shiramizu B. Assessment of minimal residual disease in childhood non-Hodgkin lymphoma by polymerase chain reaction using patient-specific primers Journal of Pediatric Hematology/Oncology. 25: 109-113. PMID 12571460 DOI: 10.1097/00043426-200302000-00005 |
0.329 |
|
| 2003 |
Cairo MS, Sposto R, Hoover-Regan M, Meadows AT, Anderson JR, Siegel SE, Kadin ME, Kjeldsberg CR, Wilson JF, Perkins SL, Lones MA, Morris E, Finlay JL. Childhood and adolescent large-cell lymphoma (LCL): a review of the Children's Cancer Group experience. American Journal of Hematology. 72: 53-63. PMID 12508269 DOI: 10.1002/Ajh.10262 |
0.426 |
|
| 2003 |
Hiotis KL, Ye W, Sposto R, Skinner KA. Predictors of breast conservation therapy: a statistical analysis of 29,000 patients Journal of Surgical Research. 114: 250. DOI: 10.1016/J.Jss.2003.08.161 |
0.322 |
|
| 2002 |
Woo CS, Silberman H, Nakamura SK, Ye W, Sposto R, Colburn W, Waisman JR, Silverstein MJ. Lymph node status combined with lymphovascular invasion creates a more powerful tool for predicting outcome in patients with invasive breast cancer American Journal of Surgery. 184: 337-340. PMID 12383896 DOI: 10.1016/S0002-9610(02)00950-9 |
0.302 |
|
| 2002 |
Nachman JB, Sposto R, Herzog P, Gilchrist GS, Wolden SL, Thomson J, Kadin ME, Pattengale P, Davis PC, Hutchinson RJ, White K. Randomized comparison of low-dose involved-field radiotherapy and no radiotherapy for children with Hodgkin's disease who achieve a complete response to chemotherapy. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 20: 3765-71. PMID 12228196 DOI: 10.1200/Jco.2002.12.007 |
0.392 |
|
| 2002 |
Jennings MT, Sposto R, Boyett JM, Vezina LG, Holmes E, Berger MS, Bruggers CS, Bruner JM, Chan KW, Dusenbery KE, Ettinger LJ, Fitz CR, Lafond D, Mandelbaum DE, Massey V, et al. Preradiation chemotherapy in primary high-risk brainstem tumors: phase II study CCG-9941 of the Children's Cancer Group. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 20: 3431-7. PMID 12177103 DOI: 10.1200/Jco.2002.04.109 |
0.401 |
|
| 2002 |
Kelly KM, Hutchinson RJ, Sposto R, Weiner MA, Lones MA, Perkins SL, Massey V. Feasibility of upfront dose-intensive chemotherapy in children with advanced-stage Hodgkin's lymphoma: preliminary results from the Children's Cancer Group Study CCG-59704. Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. 13: 107-11. PMID 12078889 DOI: 10.1093/Annonc/13.S1.107 |
0.435 |
|
| 2002 |
Pollack IF, Hamilton RL, Burnham J, Holmes EJ, Finkelstein SD, Sposto R, Yates AJ, Boyett JM, Finlay JL. Impact of proliferation index on outcome in childhood malignant gliomas: results in a multi-institutional cohort. Neurosurgery. 50: 1238-44; discussion . PMID 12015841 DOI: 10.1097/00006123-200206000-00011 |
0.362 |
|
| 2002 |
Lones MA, Perkins SL, Sposto R, Tedeschi N, Kadin ME, Kjeldsberg CR, Wilson JF, Zwick DL, Cairo MS. Non-Hodgkin's lymphoma arising in bone in children and adolescents is associated with an excellent outcome: A Children's Cancer Group report Journal of Clinical Oncology. 20: 2293-2301. PMID 11981000 DOI: 10.1200/Jco.2002.06.017 |
0.397 |
|
| 2002 |
Pollack IF, Finkelstein SD, Woods J, Burnham J, Holmes EJ, Hamilton RL, Yates AJ, Boyett JM, Finlay JL, Sposto R. Expression of p53 and prognosis in children with malignant gliomas. The New England Journal of Medicine. 346: 420-7. PMID 11832530 DOI: 10.1056/Nejmoa012224 |
0.377 |
|
| 2002 |
Sposto R. Cure model analysis in cancer: an application to data from the Children's Cancer Group. Statistics in Medicine. 21: 293-312. PMID 11782066 DOI: 10.1002/Sim.987 |
0.35 |
|
| 2001 |
Sposto R, Meadows AT, Chilcote RR, Steinherz PG, Kjeldsberg C, Kadin ME, Krailo MD, Termuhlen AM, Morse M, Siegel SE. Comparison of long-term outcome of children and adolescents with disseminated non-lymphoblastic non-Hodgkin lymphoma treated with COMP or daunomycin-COMP: A report from the Children's Cancer Group. Medical and Pediatric Oncology. 37: 432-441. PMID 11745871 DOI: 10.1002/Mpo.1226 |
0.439 |
|
| 2001 |
Skinner KA, Silberman H, Sposto R, Silverstein MJ. Palpable breast cancers are inherently different from nonpalpable breast cancers. Annals of Surgical Oncology. 8: 705-10. PMID 11597010 DOI: 10.1007/S10434-001-0705-1 |
0.309 |
|
| 2001 |
Kobrinsky NL, Sposto R, Shah NR, Anderson JR, DeLaat C, Morse M, Warkentin P, Gilchrist GS, Cohen MD, Shina D, Meadows AT. Outcomes of treatment of children and adolescents with recurrent non-Hodgkin's lymphoma and Hodgkin's disease with dexamethasone, etoposide, cisplatin, cytarabine, and l-asparaginase, maintenance chemotherapy, and transplantation: Children's Cancer Group Study CCG-5912. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 19: 2390-6. PMID 11331317 DOI: 10.1200/Jco.2001.19.9.2390 |
0.378 |
|
| 2000 |
Lones MA, Perkins SL, Sposto R, Kadin ME, Kjeldsberg CR, Wilson JF, Cairo MS. Large-Cell Lymphoma Arising in the Mediastinum in Children and Adolescents Is Associated With an Excellent Outcome: A Children’s Cancer Group Report Journal of Clinical Oncology. 18: 3845-3853. PMID 11078498 DOI: 10.1200/Jco.2000.18.22.3845 |
0.408 |
|
| 2000 |
Albright AL, Sposto R, Holmes E, Zeltzer PM, Finlay JL, Wisoff JH, Berger MS, Packer RJ, Pollack IF. Correlation of neurosurgical subspecialization with outcomes in children with malignant brain tumors. Neurosurgery. 47: 879-85; discussion 8. PMID 11014428 DOI: 10.1097/00006123-200010000-00018 |
0.343 |
|
| 2000 |
Syed AMN, Puthawala AA, Damore SJ, Cherlow JM, Austin PA, Sposto R, Ramsinghani NS. Brachytherapy for primary and recurrent nasopharyngeal carcinoma: 20 years’ experience at Long Beach Memorial International Journal of Radiation Oncology Biology Physics. 47: 1311-1321. PMID 10889385 DOI: 10.1016/S0360-3016(00)00520-4 |
0.369 |
|
| 2000 |
Gururangan S, Sposto R, Cairo MS, Meadows AT, Finlay JL. Outcome of CNS disease at diagnosis in disseminated small noncleaved-cell lymphoma and B-cell leukemia: a Children's Cancer Group study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 18: 2017-25. PMID 10811665 DOI: 10.1200/Jco.2000.18.10.2017 |
0.392 |
|
| 1999 |
Reaman GH, Sposto R, Sensel MG, Lange BJ, Feusner JH, Heerema NA, Leonard M, Holmes EJ, Sather HN, Pendergrass TW, Johnstone HS, O'Brien RT, Steinherz PG, Zeltzer PM, Gaynon PS, et al. Treatment outcome and prognostic factors for infants with acute lymphoblastic leukemia treated on two consecutive trials of the Children's Cancer Group Journal of Clinical Oncology. 17: 445-455. PMID 10080584 DOI: 10.1200/Jco.1999.17.2.445 |
0.399 |
|
| 1999 |
Arenson E, Ater J, Bank J, Bevan H, Bruner J, Cullen P, Deutsch M, Holmes E, Luerssen T, OʼBrien R, Shah N, Sposto R, Steinbok P, Strain J, Thomson J, et al. #416 A randomized phase II trial of high dose alkylating agents plus VP-16 in children with high grade astrocytoma Journal of Pediatric Hematology Oncology. 21: 325. DOI: 10.1097/00043426-199907000-00085 |
0.32 |
|
| 1999 |
Kobrinsky N, Sposto R, Shah N, Gilchrist G, Meadows A. #343 Dexamethasone, etoposide, cisplatin, Ara-C, and L-asparaginase (DECAL) treatment for recurrent non-Hodgkinʼs lymphoma and Hodgkinʼs disease: Childrenʼs Cancer Group Study CCG5912 Journal of Pediatric Hematology Oncology. 21: 319. DOI: 10.1097/00043426-199907000-00059 |
0.304 |
|
| 1999 |
L LN, Yates A, Becker L, Burger P, Davis R, Gilles F, Boyett J, Sposto R, Finlay J. #340 Outcome for children with centrally reviewed lowgrade gliomas, treated with chemotherapy with or without irradiation Journal of Pediatric Hematology/Oncology. 21: 319. DOI: 10.1097/00043426-199907000-00058 |
0.355 |
|
| 1993 |
Anderson JR, Jenkin RD, Wilson JF, Kjeldsberg CR, Sposto R, Chilcote RR, Coccia PF, Exelby PR, Siegel S, Meadows AT. Long-term follow-up of patients treated with COMP or LSA2L2 therapy for childhood non-Hodgkin's lymphoma: a report of CCG-551 from the Childrens Cancer Group. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 11: 1024-32. PMID 8501488 DOI: 10.1200/Jco.1993.11.6.1024 |
0.419 |
|
| 1990 |
Evans AE, Jenkin RD, Sposto R, Ortega JA, Wilson CB, Wara W, Ertel IJ, Kramer S, Chang CH, Leikin SL. The treatment of medulloblastoma. Results of a prospective randomized trial of radiation therapy with and without CCNU, vincristine, and prednisone. Journal of Neurosurgery. 72: 572-82. PMID 2319316 DOI: 10.3171/Jns.1990.72.4.0572 |
0.416 |
|
| 1989 |
Sposto R, Ertel IJ, Jenkin RD, Boesel CP, Venes JL, Ortega JA, Evans AE, Wara W, Hammond D. The effectiveness of chemotherapy for treatment of high grade astrocytoma in children: results of a randomized trial. A report from the Childrens Cancer Study Group. Journal of Neuro-Oncology. 7: 165-77. PMID 2550594 DOI: 10.1007/Bf00165101 |
0.44 |
|
| 1987 |
Jenkin RDT, Boesel C, Ertel I, Evans A, Hittle R, Ortega J, Sposto R, Wara W, Wilson C, Anderson J. Brain-stem tumors in childhood: a prospective randomized trial of irradiation with and without adjuvant CCNU, VCR, and prednisone. A report of the Childrens Cancer Study Group. Journal of Neurosurgery. 66: 227-233. PMID 3806204 DOI: 10.3171/Jns.1987.66.2.0227 |
0.396 |
|
| 1987 |
Wilson JF, Kjeldsberg CR, Sposto R, Jenkin RDT, Chilcote RR, Coccia P, Exelby RR, Kersey J, Meadows A, Siegel S, Hammond D. The pathology of non-Hodgkin's lymphoma of childhood: II. Reproducibility and relevance of the histologic classification of “undifferentiated” lymphomas (Burkitt's versus non-Burkitt's) Human Pathology. 18: 1008-1014. PMID 3653876 DOI: 10.1016/S0046-8177(87)80217-4 |
0.338 |
|
| 1987 |
Sposto R, Krailo MD. Use of unequal allocation in survival trials. Statistics in Medicine. 6: 119-125. PMID 3589241 DOI: 10.1002/Sim.4780060204 |
0.311 |
|
| 1986 |
Waral W, Edwards M, Levin V, Heideman R, Urtasun R, Diaz R, Silver P, Sposto R. A new treatment regimen for brainstem glioma: A pilot study of the brain tumor research center and childrens cancer study group International Journal of Radiation Oncology*Biology*Physics. 12: 143-144. DOI: 10.1016/0360-3016(86)90604-8 |
0.342 |
|
| 1985 |
Sposto R, Sather HN. Determining the duration of comparative clinical trials while allowing for cure Journal of Chronic Diseases. 38: 683-690. PMID 4019705 DOI: 10.1016/0021-9681(85)90022-0 |
0.307 |
|
| 1984 |
Packer RJ, Sutton LN, Rorke LB, Littman PA, Sposto R, Rosenstock JG, Bruce DA, Schut L. Prognostic importance of cellular differentiation in medulloblastoma of childhood. Journal of Neurosurgery. 61: 296-301. PMID 6737054 DOI: 10.3171/Jns.1984.61.2.0296 |
0.35 |
|
| 1984 |
Jenkin RD, Anderson JR, Chilcote RR, Coccia PF, Exelby PR, Kersey JH, Kushner JH, Meadows AT, Siegel SE, Sposto R. The treatment of localized non-Hodgkin's lymphoma in children: a report from the Children's Cancer Study Group. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 2: 88-97. PMID 6366148 DOI: 10.1200/Jco.1984.2.2.88 |
0.398 |
|
| Show low-probability matches. |